BR100 Increased By (0.54%)
BR30 Increased By (0.71%)
KSE100 Increased By (0.47%)
KSE30 Increased By (0.46%)
AGHA 6.50 Increased By ▲ 0.05 (0.78%)
BECO 4.14 Decreased By ▼ -0.02 (-0.48%)
BML 58.62 Increased By ▲ 1.31 (2.29%)
BOP 28.23 Increased By ▲ 0.08 (0.28%)
CNERGY 12.52 Increased By ▲ 0.11 (0.89%)
CSIL 5.35 Decreased By ▼ -0.01 (-0.19%)
FCCL 51.30 Decreased By ▼ -0.36 (-0.7%)
FFL 13.94 Increased By ▲ 0.04 (0.29%)
FNEL 1.09 Increased By ▲ 0.01 (0.93%)
KEL 5.73 Increased By ▲ 0.01 (0.17%)
KOSM 5.31 Decreased By ▼ -0.02 (-0.38%)
LOTCHEM 24.16 Decreased By ▼ -0.09 (-0.37%)
MLCF 89.85 Increased By ▲ 0.21 (0.23%)
NBP 157.05 Increased By ▲ 0.48 (0.31%)
NCPL 51.50 Increased By ▲ 4.48 (9.53%)
NPL 56.88 Increased By ▲ 4.92 (9.47%)
OGDC 303.05 Increased By ▲ 3.04 (1.01%)
PACE 9.32 Increased By ▲ 0.06 (0.65%)
PAEL 33.07 Increased By ▲ 0.06 (0.18%)
PIBTL 13.10 Decreased By ▼ -0.09 (-0.68%)
PPL 216.67 Increased By ▲ 2.35 (1.1%)
PRL 99.88 Decreased By ▼ -1.56 (-1.54%)
PTC 52.25 Increased By ▲ 0.01 (0.02%)
SSGC 23.21 Increased By ▲ 0.06 (0.26%)
TBL 8.96 Decreased By ▼ -0.13 (-1.43%)
TELE 6.98 No Change ▼ 0.00 (0%)
TPL 22.18 Increased By ▲ 0.14 (0.64%)
TPLP 11.41 Decreased By ▼ -0.28 (-2.4%)
TREET 23.27 Increased By ▲ 0.47 (2.06%)
TRG 56.83 Decreased By ▼ -0.30 (-0.53%)

Highnoon Laboratories Limited marked a significant milestone with the groundbreaking ceremony of Project FORCE, its greenfield manufacturing expansion initiative, held at the Special Economic Zone, Quaid-e-Azam Business Park, Sheikhupura.

Project FORCE is a strategic investment aimed at establishing a world-class, efficient, and globally compliant pharmaceutical manufacturing facility in Pakistan. The new facility is designed to strengthen Highnoon’s manufacturing footprint, support future growth ambitions and enhance the Company’s ability to serve both domestic and international markets.

The facility aims to align with internationally recognized quality and regulatory standards, reinforcing Highnoon’s commitment to operational excellence, quality assurance, and sustainable manufacturing practices. The project underscores the Company’s long-term vision to invest in advanced infrastructure and build resilient capabilities in an increasingly competitive global pharmaceutical landscape.

The groundbreaking of Project FORCE reflects Highnoon Laboratories Limited’s continued focus on innovation, scale, and global competitiveness, while contributing to the growth and development of Pakistan’s pharmaceutical sector.

Comments

Comments are closed for this article.